Effects of Resveratrol and Nebivolol on Isolated Vascular and Cardiac Tissues from Young Rats

The mechanisms by which resveratrol and nebivolol induce vasodilation are not clearly understood. It has been postulated that both agents stimulate the production of nitric oxide; however, this remains to be conclusively established. The major aim of this study was to examine the vasodilatory and an...

Full description

Saved in:
Bibliographic Details
Main Authors: Candice Pullen (Author), Fiona R. Coulson (Author), Andrew Fenning (Author)
Format: Book
Published: Hindawi Limited, 2014-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_3a4ff0fa48ef4f22ae0c4d0cfef834b2
042 |a dc 
100 1 0 |a Candice Pullen  |e author 
700 1 0 |a Fiona R. Coulson  |e author 
700 1 0 |a Andrew Fenning  |e author 
245 0 0 |a Effects of Resveratrol and Nebivolol on Isolated Vascular and Cardiac Tissues from Young Rats 
260 |b Hindawi Limited,   |c 2014-01-01T00:00:00Z. 
500 |a 1687-6334 
500 |a 1687-6342 
500 |a 10.1155/2014/720386 
520 |a The mechanisms by which resveratrol and nebivolol induce vasodilation are not clearly understood. It has been postulated that both agents stimulate the production of nitric oxide; however, this remains to be conclusively established. The major aim of this study was to examine the vasodilatory and antiarrhythmic effects of both resveratrol and nebivolol and to provide further insight into possible mechanisms of action. Cardiac and vascular tissues were isolated from healthy male rodents. Results indicate that resveratrol and nebivolol decrease the action potential duration and induce mild vasorelaxation in aortic and mesenteric segments. Relaxation induced by resveratrol was prevented by the addition of verapamil, Nω-nitro-L-arginine-methyl ester, and 4-aminopyridine. This suggests that nebivolol and resveratrol act as putative antiarrhythmic and vasodilatory agents in vitro through possible indirect nitric oxide mechanisms. 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Advances in Pharmacological Sciences, Vol 2014 (2014) 
787 0 |n http://dx.doi.org/10.1155/2014/720386 
787 0 |n https://doaj.org/toc/1687-6334 
787 0 |n https://doaj.org/toc/1687-6342 
856 4 1 |u https://doaj.org/article/3a4ff0fa48ef4f22ae0c4d0cfef834b2  |z Connect to this object online.